Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone versus placebo for conduct disorder in children and adolescents
2011-000567-26Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in conduct disorder (CD) comparing Risperidone with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2012; status: completed.
02
Drugs
risperidone
03
Conditions
conduct disorder (CD)
Beyond the preview
Go deeper on 2011-000567-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000567-26.